DOCSLIB.ORG

ARK Invest Change to the Founds Holdings

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ARK Invest Change to the Founds Holdings IZRL - Israel Innovative Technology ETF page 1 of 8 Assets that ARK invest Sold out off No new assets detected page 2 of 8 New assets that ARK invest have added to their funds No new assets detected page 3 of 8 Assets where ARK invest decrease number of shares No new assets detected page 4 of 8 Assets where ARK invest increase number of shares Compared to 11-01-2021 Date Fund Ticker Shares bought Shares bought % Company 12-01-2021 IZRL AYLA 21.216 17,19% AYALA PHARMACEUTICALS INC 12-01-2021 IZRL SSYS 18.904 16,46% STRATASYS LTD 12-01-2021 IZRL GILT 58.055 16,13% GILAT SATELLITE NETWORKS LTD 12-01-2021 IZRL CGEN 17.187 15,98% COMPUGEN LTD 12-01-2021 IZRL PSTI 26.877 15,55% PLURISTEM THERAPEUTICS INC 12-01-2021 IZRL RADA 41.905 15,52% RADA ELECTRONIC INDS LTD 12-01-2021 IZRL PERI 36.431 15,50% PERION NETWORK LTD 12-01-2021 IZRL FTAL 4.199 15,48% FATTAL HOLDINGS 1998 LTD 12-01-2021 IZRL NVMI 4.811 15,43% NOVA MEASURING INSTRUMENTS 12-01-2021 IZRL DANE 2.261 15,42% DANEL (ADIR YEOSHUA) LTD 12-01-2021 IZRL BVXV 6.902 15,40% BIONDVAX PHARMACEUTICALS-ADR 12-01-2021 IZRL WIX 969 15,37% WIX.COM LTD 12-01-2021 IZRL INMD 6.834 15,35% INMODE LTD 12-01-2021 IZRL CYBR 2.465 15,33% CYBERARK SOFTWARE LTD/ISRAEL 12-01-2021 IZRL RDHL 27.540 15,32% REDHILL BIOPHARMA LTD-SP ADR 12-01-2021 IZRL ESLT 2.312 15,32% ELBIT SYSTEMS LTD 12-01-2021 IZRL MTRX 11.458 15,32% MATRIX IT LTD 12-01-2021 IZRL TARO 4.624 15,31% TARO PHARMACEUTICAL INDUS 12-01-2021 IZRL CRNT 107.746 15,31% CERAGON NETWORKS LTD 12-01-2021 IZRL CAMT 15.079 15,30% CAMTEK LTD 12-01-2021 IZRL CHKP 2.159 15,30% CHECK POINT SOFTWARE TECH 12-01-2021 IZRL TEVA 29.614 15,29% TEVA PHARMACEUTICAL-SP ADR 12-01-2021 IZRL AUDC 8.245 15,28% AUDIOCODES LTD 12-01-2021 IZRL HLAN 6.307 15,28% HILAN LTD 12-01-2021 IZRL BEZQ 226.627 15,26% BEZEQ THE ISRAELI TELECOM CO 12-01-2021 IZRL GMDA 52.938 15,26% GAMIDA CELL LTD 12-01-2021 IZRL URGN UQ 12.121 15,25% UROGEN PHARMA LTD 12-01-2021 IZRL RDWR 11.203 15,25% RADWARE LTD 12-01-2021 IZRL TSEM 13.906 15,24% TOWER SEMICONDUCTOR LTD 12-01-2021 IZRL ALLT 27.030 15,24% ALLOT LTD 12-01-2021 IZRL ONE 3.400 15,22% ONE SOFTWARE TECHNOLOGIES LT 12-01-2021 IZRL KMDA 34.357 15,20% KAMADA LTD 12-01-2021 IZRL PTNR 68.986 15,17% PARTNER COMMUNICATIONS CO 12-01-2021 IZRL SILC 7.667 15,17% SILICOM LTD 12-01-2021 IZRL SPNS 8.942 15,16% SAPIENS INTERNATIONAL CORP 12-01-2021 IZRL NICE 1.156 15,15% NICE LTD - SPON ADR 12-01-2021 IZRL BATM 181.356 15,13% BATM ADVANCED COMMUNICATIONS 12-01-2021 IZRL CEL 69.088 15,02% CELLCOM ISRAEL LTD 12-01-2021 IZRL ITRN 19.159 14,94% ITURAN LOCATION AND CONTROL 12-01-2021 IZRL FVRR 1.598 14,32% FIVERR INTERNATIONAL LTD 12-01-2021 IZRL PYPD 20.298 13,24% POLYPID LTD 12-01-2021 IZRL 10.021 9,49% MORGAN STANLEY GOVT INSTL 8035 page 5 of 8 +15,5% PERI PERION NETWORK LTD +36.431 3,77% 271.481 shares 3.825.167,29 $ +16,5% SSYS STRATASYS LTD +18.904 3,60% 133.728 shares 3.654.786,24 $ +15,5% FTAL FATTAL HOLDINGS 1998 LTD +4.199 3,51% 31.316 shares 3.560.501,15 $ +15,2% ONE ONE SOFTWARE TECHNOLOGIES LT +3.400 3,51% 25.737 shares 3.560.472,31 $ +15,3% GMDA GAMIDA CELL LTD +52.938 3,39% 399.876 shares 3.434.934,84 $ +14,3% FVRR FIVERR INTERNATIONAL LTD +1.598 3,19% 12.756 shares 3.238.238,16 $ +15,5% RADA RADA ELECTRONIC INDS LTD +41.905 3,10% 311.937 shares 3.144.324,96 $ +15,3% CYBR CYBERARK SOFTWARE LTD/ISRAEL +2.465 2,97% 18.543 shares 3.010.085,19 $ +15,2% TSEM TOWER SEMICONDUCTOR LTD +13.906 2,91% 105.127 shares 2.948.812,35 $ +15,2% ALLT ALLOT LTD +27.030 2,88% 204.375 shares 2.922.562,50 $ +14,9% ITRN ITURAN LOCATION AND CONTROL +19.159 2,84% 147.369 shares 2.884.011,33 $ +16,1% GILT GILAT SATELLITE NETWORKS LTD +58.055 2,82% 417.939 shares 2.862.882,15 $ +15,4% NVMI NOVA MEASURING INSTRUMENTS +4.811 2,75% 35.988 shares 2.789.429,88 $ +15,2% PTNR PARTNER COMMUNICATIONS CO +68.986 2,72% 523.606 shares 2.762.078,81 $ +15,4% INMD INMODE LTD +6.834 2,70% 51.353 shares 2.734.033,72 $ +15,4% DANE DANEL (ADIR YEOSHUA) LTD +2.261 2,70% 16.926 shares 2.742.562,99 $ +15,3% TARO TARO PHARMACEUTICAL INDUS +4.624 2,67% 34.821 shares 2.711.163,06 $ page 6 of 8 +15,0% CEL CELLCOM ISRAEL LTD +69.088 2,63% 528.945 shares 2.662.573,48 $ +15,3% CAMT CAMTEK LTD +15.079 2,62% 113.609 shares 2.658.450,60 $ +15,2% SILC SILICOM LTD +7.667 2,60% 58.205 shares 2.634.358,30 $ +15,3% TEVA TEVA PHARMACEUTICAL-SP ADR +29.614 2,58% 223.352 shares 2.617.685,44 $ +15,3% CRNT CERAGON NETWORKS LTD +107.746 2,50% 811.565 shares 2.540.198,45 $ +15,2% RDWR RADWARE LTD +11.203 2,39% 84.688 shares 2.423.770,56 $ +15,2% NICE NICE LTD - SPON ADR +1.156 2,39% 8.784 shares 2.424.823,20 $ +15,3% HLAN HILAN LTD +6.307 2,32% 47.581 shares 2.348.261,18 $ +15,3% ESLT ELBIT SYSTEMS LTD +2.312 2,31% 17.407 shares 2.340.650,67 $ +15,3% CHKP CHECK POINT SOFTWARE TECH +2.159 2,13% 16.268 shares 2.160.227,72 $ +15,2% SPNS SAPIENS INTERNATIONAL CORP +8.942 2,12% 67.934 shares 2.145.355,72 $ +15,3% MTRX MATRIX IT LTD +11.458 1,92% 86.269 shares 1.948.261,56 $ +15,3% "URGN UQ" UROGEN PHARMA LTD +12.121 1,90% 91.594 shares 1.927.595,73 $ +15,4% WIX WIX.COM LTD +969 1,87% 7.273 shares 1.897.016,59 $ +15,2% KMDA KAMADA LTD +34.357 1,82% 260.358 shares 1.849.689,07 $ +13,2% PYPD POLYPID LTD +20.298 1,81% 173.578 shares 1.836.455,24 $ +15,3% AUDC AUDIOCODES LTD +8.245 1,81% 62.199 shares 1.833.626,52 $ page 7 of 8 +15,1% BATM BATM ADVANCED COMMUNICATIONS +181.356 1,76% 1.379.663 shares 1.780.690,89 $ +17,2% AYLA AYALA PHARMACEUTICALS INC +21.216 1,74% 144.650 shares 1.764.730,00 $ +15,3% BEZQ BEZEQ THE ISRAELI TELECOM CO +226.627 1,70% 1.711.387 shares 1.722.393,14 $ +15,5% PSTI PLURISTEM THERAPEUTICS INC +26.877 1,64% 199.722 shares 1.659.689,82 $ +16,0% CGEN COMPUGEN LTD +17.187 1,58% 124.712 shares 1.597.560,72 $ +15,3% RDHL REDHILL BIOPHARMA LTD-SP ADR +27.540 1,54% 207.249 shares 1.558.512,48 $ +15,4% BVXV BIONDVAX PHARMACEUTICALS-ADR +6.902 0,19% 51.716 shares 193.935,00 $ +9,5% MORGAN STANLEY GOVT INSTL 8035 +10.021 0,11% 115.667 shares 115.666,52 $ page 8 of 8.
Load more

Recommended publications
  • Semiconductor Sector Report
    SEMICONDUCTOR SECTOR REPORT SAVVIAN, LLC 150 CALIFORNIA STREET, SAN FRANCISCO, CA 94111 | www.savvian.com | 415.318.3600 MARKET HIGHLIGHTS Inside this issue MARKETMARKET HIGHLIGHTSHIGHLIGHTS STMicroelectronics (NYSE:STM, Paris: STM.PA, Milan:STM.MI), Intel (NASDAQ:INTC) and Francisco Partners entered into a definitive agreement to create a new independent semiconductor company from the key assets of businesses which Market Highlights last year generated approximately $3.6Bn in combined annual revenue. The new company’s strategic focus will be on Summary Performance supplying flash memory solutions for a variety of consumer and industrial devices. Two Global Positioning Systems (GPS) related private companies were acquired, confirming the emerging significance of Observations GPS-related technology in the semiconductor industry. In early June, Broadcom (NASDAQ: BRCM) signed a definitive Trading Data agreement to acquire Global Locate, Inc for $226MM. In late June, GPS chipmaker SiRF Technology Holdings Inc. (NASDAQ: SIRF) announced the purchase of Centrality Communications for $283MM. Transaction Activity Early in the quarter, Linear Technology announced a $3Bn Accelerated Stock Repurchase in combination with $1.7Bn in Savvian Update privately placed convertible senior notes. This financing was noticed and emulated by numerous other large capitalization companies who are seeking to optimize their capital structures in light of increased shareholder pressure and private equity interest. Applied Materials (NASDAQ:AMAT) acquired HCT Shaping Systems, a Swiss solar company, for CHF 583MM ($475MM) in cash, extending the company’s reach in the solar industry. The acquisition advances AMAT’s strategy leveraging its semiconductor process capability into complementary adjacent markets. Zarlink (NYSE / TSX: ZL) signed a definitive agreement to acquire privately held Legerity Holdings for $135MM in cash.
    [Show full text]
  • The Advisory Committee for the FTSE Med-100 Index, Had Its Semi-Annual Meeting Today, 14Th of November 2012
    The Advisory Committee for the FTSE Med-100 Index, had its semi-annual meeting today, 14th of November 2012. The FTSE Med-100 Index which was launched on the 19/6/2003 is composed of 100 stocks of three Exchanges (Athens Exchange, Tel-Aviv Stock Exchange and Cyprus Stock Exchange). The Advisory Committee of the index is comprised of representatives from the three Exchanges and also from the global index provider “FTSE Group”. During this meeting, the committee reviewed the operation of the index for the six months period between May 2012 – October 2012, in accordance with its ground rules, which follow international standards. Having applied the index rules, no changes are applicable in the constituent list of the index. The index is composed of 65 stocks listed on the Tel-Aviv Stock Exchange, 22 stocks listed on the Athens Exchange and 13 stocks listed on the Cyprus Stock Exchange. The list of the constituent 100 companies is as follows: Country Capital value (Euro million) 1 Teva Pharmaceutical Israel 27.292,7 2 Israel Chemicals Israel 12.219,9 3 Coca-Cola HBC Greece 6.031,4 4 Israel Corporation Israel 4.035,7 5 Bank Hapoalim Israel 3.986,6 6 Bank Leumi Israel 3.646,5 7 Bezeq Israel 2.556,6 8 Azrieli Group Israel 2.097,3 9 Mellanox Technologies Israel 1.947,6 10 Hellenic Petroleum (Cr) Greece 1.845,0 11 Natl Bank Of Greece Greece 1.710,1 12 Hellenic Telecom Greece 1.670,3 13 Delek Group Israel 1.668,5 14 Nice Systems Israel 1.603,7 15 Mizrahi Tefahot Bank Ltd.
    [Show full text]
  • Market Cap Close ADV 1598 67Th Pctl 745,214,477.91 $ 23.96
    Market Cap Close ADV 1598 67th Pctl $ 745,214,477.91 $ 23.96 225,966.94 801 33rd Pctl $ 199,581,478.89 $ 10.09 53,054.83 2399 Ticker_ Listing_ Effective_ Revised Symbol Security_Name Exchange Date Mkt Cap Close ADV Stratum Stratum AAC AAC Holdings, Inc. N 20160906 M M M M-M-M M-M-M AAMC Altisource Asset Management Corp A 20160906 L M L L-M-L L-M-L AAN Aarons Inc N 20160906 H H H H-H-H H-H-H AAV Advantage Oil & Gas Ltd N 20160906 H L M H-L-M H-M-M AB Alliance Bernstein Holding L P N 20160906 H M M H-M-M H-M-M ABG Asbury Automotive Group Inc N 20160906 H H H H-H-H H-H-H ABM ABM Industries Inc. N 20160906 H H H H-H-H H-H-H AC Associated Capital Group, Inc. N 20160906 H H L H-H-L H-H-L ACCO ACCO Brand Corp. N 20160906 H L H H-L-H H-L-H ACU Acme United A 20160906 L M L L-M-L L-M-L ACY AeroCentury Corp A 20160906 L L L L-L-L L-L-L ADK Adcare Health System A 20160906 L L L L-L-L L-L-L ADPT Adeptus Health Inc. N 20160906 M H H M-H-H M-H-H AE Adams Res Energy Inc A 20160906 L H L L-H-L L-H-L AEL American Equity Inv Life Hldg Co N 20160906 H M H H-M-H H-M-H AF Astoria Financial Corporation N 20160906 H M H H-M-H H-M-H AGM Fed Agricul Mtg Clc Non Voting N 20160906 M H M M-H-M M-H-M AGM A Fed Agricultural Mtg Cla Voting N 20160906 L H L L-H-L L-H-L AGRO Adecoagro S A N 20160906 H L H H-L-H H-L-H AGX Argan Inc N 20160906 M H M M-H-M M-H-M AHC A H Belo Corp N 20160906 L L L L-L-L L-L-L AHL ASPEN Insurance Holding Limited N 20160906 H H H H-H-H H-H-H AHS AMN Healthcare Services Inc.
    [Show full text]
  • Advancing Cell Therapeutic Products for Clinical Use
    Advancing cell therapeutic products for clinical use 1 Proprietary data of Pluristem Therapeutics Inc. Forward Looking Statement This presentation concerning Pluristem Therapeutics may include forward- looking statements which represent Pluristem Therapeutics' expectations or beliefs regarding future events. I caution that such statements involve risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements. Consequently, all such forward-looking statements are qualified by the cautionary language and risk factors set forth in Pluristem Therapeutics' periodic and other reports filed with the SEC. There can be no assurance that the actual results, events or developments referenced in such forward-looking statements will occur or be realized. Pluristem Therapeutics assumes no obligation to update these forward- looking statements to reflect actual results, changes in assumptions or changes in factors affecting such forward-looking statements. www.pluristem.com 2 Proprietary data of Pluristem Therapeutics Inc. Corporate Overview • Cell therapy company (NasdaqCM: PSTI, TASE: PSTI) • Using off-the-shelf, placenta-derived cells to achieve both local and systemic therapeutic effects – no tissue matching needed • First-in-class 3D cell culturing technology allowing for efficient, controlled production of multiple cell products in commercial quantities – “the process is the product” • Active with regulators in the U.S., EU, S. Korea, Australia & Israel • Demonstrated safety and efficacy in 3 clinical studies (two Phase I and one Phase I/II study) 3 Proprietary data of Pluristem Therapeutics Inc. Financial Overview • Market Cap: ~ $200 million • Cash and marketable securities: $41 million (March, 2015) • No debt • Net burn: ~ $23 million • 165 employees (16 PhD, 4 MD) • IP Ownership: over 40 granted patents and ~150 pending applications 4 Proprietary data of Pluristem Therapeutics Inc.
    [Show full text]
  • TOWER SEMICONDUCTOR LTD. (Translation of Registrant's Name Into English)
    FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the month January 2021 No. 1 TOWER SEMICONDUCTOR LTD. (Translation of registrant's name into English) Ramat Gavriel Industrial Park P.O. Box 619, Migdal Haemek, Israel 2310502 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes ☐ No ☒ On January 5, 2021, the Registrant Announce Program Creating an Integrated-Laser-on-Silicon Photonics Foundry Process SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TOWER SEMICONDUCTOR LTD. Date: January 5, 2021 By: /s/ Nati Somekh Name: Nati Somekh Title: Corporate Secretary NEWS ANNOUNCEMENT FOR IMMEDIATE RELEASE Tower Semiconductor Announces Program Creating an Integrated-Laser-on-Silicon Photonics Foundry Process Advanced process to be developed with partial funding from the DARPA LUMOS program addressing high-speed communications MIGDAL HAEMEK, Israel, January 05, 2021 – Tower Semiconductor (NASDAQ/TASE: TSEM), the leader in high-value analog semiconductor foundry solutions, today announced that it is participating in the LUMOS program, with partial support from DARPA, to create a semiconductor foundry integrated-laser-on-silicon photonics process. This process will combine high performance III-V laser diodes with Tower’s PH18 production silicon photonics platform.
    [Show full text]
  • White Phosphorus (WP) and Smoke Mortars in 60Mm, 81Mm and 120Mm Calibers, Equipped with Point Detonating, Proximity and Electronic Time Fuses
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2010 Commission File No. 0-28998 ELBIT SYSTEMS LTD. (Exact name of registrant as specified in its charter and translation of registrant’s name into English) Israel (Jurisdiction of incorporation or organization) Advanced Technology Center, Haifa 31053, Israel (Address of principal executive offices) Joseph Gaspar c/o Elbit Systems Ltd. P.O. Box 539 Advanced Technology Center Haifa 31053 Israel Tel: 972-4-831-6404 Fax: 972-4-831-6944 E-mail: [email protected] (Name, telephone, e-mail and/or facsimile number and address of Company contact person) Securities registered or to be registered pursuant to Section 12(b) of the Act: Ordinary Shares, nominal value 1.0 New Israeli Shekels per share (Title of Class) The NASDAQ Global Select Market (Name of each Exchange on which registered) Securities registered or to be registered pursuant to Section 12(g) of the Act: Not Applicable Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: Not Applicable Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 42,693,340 Ordinary Shares Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
    [Show full text]
  • TOWER SEMICONDUCTOR LTD. (Translation of Registrant's Name Into English)
    FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the month May 2018 No. 3 TOWER SEMICONDUCTOR LTD. (Translation of registrant's name into English) Ramat Gavriel Industrial Park P.O. Box 619, Migdal Haemek, Israel 2310502 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes ☐ No ☒ On May 9, 2018, the Registrant and Newsight Imaging Announce Advanced CMOS Image Sensor Chips for LiDAR used in ADAS and Autonomous Vehicles SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TOWER SEMICONDUCTOR LTD. Date: May 9, 2018 By: /s/ Nati Somekh Name: Nati Somekh Title: Corporate Secretary NEWS ANNOUNCEMENT FOR IMMEDIATE RELEASE TowerJazz and Newsight Imaging Announce Advanced CMOS Image Sensor Chips for LiDAR used in ADAS and Autonomous Vehicles Customized for high volume markets of automotive visual safety solutions as well as drones and autonomous home appliance robots MIGDAL HAEMEK and NESS ZIONA, Israel, May 9, 2018 – TowerJazz, the global specialty foundry leader, and Newsight Imaging, today announced production of Newsight’s advanced CMOS image sensor (CIS) chips and camera modules, customized for very high volume LiDAR and machine vision markets, combining sensors, digital algorithms and pixel array on the same chip.
    [Show full text]
  • NASDAQ Stock Market
    Nasdaq Stock Market Friday, December 28, 2018 Name Symbol Close 1st Constitution Bancorp FCCY 19.75 1st Source SRCE 40.25 2U TWOU 48.31 21st Century Fox Cl A FOXA 47.97 21st Century Fox Cl B FOX 47.62 21Vianet Group ADR VNET 8.63 51job ADR JOBS 61.7 111 ADR YI 6.05 360 Finance ADR QFIN 15.74 1347 Property Insurance Holdings PIH 4.05 1-800-FLOWERS.COM Cl A FLWS 11.92 AAON AAON 34.85 Abiomed ABMD 318.17 Acacia Communications ACIA 37.69 Acacia Research - Acacia ACTG 3 Technologies Acadia Healthcare ACHC 25.56 ACADIA Pharmaceuticals ACAD 15.65 Acceleron Pharma XLRN 44.13 Access National ANCX 21.31 Accuray ARAY 3.45 AcelRx Pharmaceuticals ACRX 2.34 Aceto ACET 0.82 Achaogen AKAO 1.31 Achillion Pharmaceuticals ACHN 1.48 AC Immune ACIU 9.78 ACI Worldwide ACIW 27.25 Aclaris Therapeutics ACRS 7.31 ACM Research Cl A ACMR 10.47 Acorda Therapeutics ACOR 14.98 Activision Blizzard ATVI 46.8 Adamas Pharmaceuticals ADMS 8.45 Adaptimmune Therapeutics ADR ADAP 5.15 Addus HomeCare ADUS 67.27 ADDvantage Technologies Group AEY 1.43 Adobe ADBE 223.13 Adtran ADTN 10.82 Aduro Biotech ADRO 2.65 Advanced Emissions Solutions ADES 10.07 Advanced Energy Industries AEIS 42.71 Advanced Micro Devices AMD 17.82 Advaxis ADXS 0.19 Adverum Biotechnologies ADVM 3.2 Aegion AEGN 16.24 Aeglea BioTherapeutics AGLE 7.67 Aemetis AMTX 0.57 Aerie Pharmaceuticals AERI 35.52 AeroVironment AVAV 67.57 Aevi Genomic Medicine GNMX 0.67 Affimed AFMD 3.11 Agile Therapeutics AGRX 0.61 Agilysys AGYS 14.59 Agios Pharmaceuticals AGIO 45.3 AGNC Investment AGNC 17.73 AgroFresh Solutions AGFS 3.85
    [Show full text]
  • Israel and the Alien Tort Statute
    Summer 2014 No.54 JTheUSTICE magazine of the International Association of Jewish Lawyers and Jurists In this issue The International Court of Justice Adjudicating the Arab-Israel Disputes? Boycotts, Divestment, Sanctions and the Law Israel and the Alien Tort Statute Corporations and Human Rights Zivotofsky v. Kerry - A Historical Constitutional Battle Preachers of Hate and Freedom of Expression UNRWA Panel at UN IAJLJ Activities The International Association of Jewish Lawyers and Jurists Honorary President: Hadassa Ben-Itto, Judge (Ret.) (Israel) Life time Member: Irwin Cotler, Prof. (Canada) Honorary Vice Presidents: Joseph Roubache (France) Oreste Bisazza Terracini, Dr. (Italy) Executive Committee: Board of Governors: President: Irit Kohn (Israel) Irit Kohn (Israel) Haim Klugman (Israel) Avraham (Avi) D. Doron (Israel) Deputy President: Meir Rosenne, Dr. (Israel) Haim Klugman (Israel) Mirella M. Bamberger (Israel) Alyza D. Lewin (USA) Vice President and Treasurer: Marcos Arnoldo Grabivker, Judge (Argentina) Avraham (Avi) D. Doron (Israel) Maurizio Ruben (Italy) Alex Hertman (Israel) Vice President and Coordinator with Amos Shapira, Prof. (Israel) International Organizations: Avishai Sapir (Israel) Meir Rosenne, Dr. (Israel) David Pardes (Belgium) Dov Shefi, Brig. (Ret.) (Israel) Vice President and Secretary General: Edna Bekenstein, Judge (Ret.) (Israel) Mirella M. Bamberger (Israel) Edna Kaplan-Hagler, Judge (Ret.) Dr. (Israel) Efraim (Efi) Chalamish, Dr. (USA) Vice Presidents: Ethia Simha (Israel) Alyza D. Lewin (USA) Jeremy D. Margolis (USA) Marcos Arnoldo Grabivker, Judge (Argentina) Jimena Bronfman (Chile) Maurizio Ruben (Italy) Jonathan Lux (UK) Lipa Meir, Dr. (Israel) Academic Adviser: Mala Tabory, Dr. (Israel) Yaffa Zilbershats, Prof. (Israel) Maria Canals De-Cediel, Dr. (Switzerland) Meir Linzen (Israel) Representatives to the U.N.
    [Show full text]
  • Market Guide for Enterprise SBC
    Market Guide for Enterprise SBC Published: 29 December 2017 ID: G00343746 Analyst(s): Rafael A Benitez E-SBCs terminate SIP trunks from provider networks and provide enterprise communications security, interoperability, remote worker support, call control and resiliency capabilities. This report gives I&O leaders information on E-SBC vendors and the capabilities of their product lines. Key Findings ■ A software-defined-network-centric approach to E-SBC, including SBC as a VNF, vCPE support and alignment with NFV orchestration frameworks, is a priority to E-SBC vendors. ■ The market for E-SBCs is expanding beyond North America and EMEA to Asia/Pacific as enterprises deploy SIP trunk service globally. ■ Enterprises are expanding E-SBC use beyond SIP trunks to include user-side security and interoperability of endpoints with cloud services. ■ Increased adoption of WebRTC-based voice and video services has made WebRTC gateway functionality a key investment area among E-SBC vendors. ■ Leading E-SBC suppliers provide automation and deployment simplification of E-SBCs with configuration templates for the most prominent PBXs, and SIP trunk service providers. Recommendations When planning unified communications, I&O leaders should: ■ Use E-SBCs to provide secure connectivity and quality of service optimization to remote voice and video devices that do not use VPN access. E-SBCs are tailored for voice and video services, whereas standard firewalls are not. ■ Optimize call routing in global SIP trunking implementations by using E-SBCs with advanced dial plan and session management. Optimized routing can reduce cost and provide a better UX by selecting paths where media will have less delay, a higher class of service or both.
    [Show full text]
  • Biolinerx Ltd. (Translation of Registrant’S Name Into English) ______
    SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2018 _______________________ BioLineRx Ltd. (Translation of registrant’s name into English) _______________________ 2 HaMa’ayan Street Modi’in 7177871, Israel (Address of Principal Executive Offices) _______________________ Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☑ Form 40-F ☐ Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: Yes ☐ No ☑ The registrant hereby announces that it has entered into an employment agreement with Hillit Mannor Shachar, M.D., MBA, M.S.F.S., to serve as its new Vice President Business Development, effective April 1, 2018. Dr. Shachar will be responsible for BioLineRx’s business development, commercialization of assets and pipeline strategy. Dr. Shachar joins BioLineRx with over 15 years of experience in senior business development, corporate development and venture capital positions in the life sciences field. Her recent experience has included service as Vice President Business Development of Pluristem Therapeutics (NASDAQ:PSTI), a leading developer of placenta-based cell therapy products, and Director of New Business Development at West Pharmacuetical Services. In addition, Dr. Shachar has served at several life science companies and venture capital funds, including Apax Partners, Nektar Therapeutics, Orex Computed Radiography, Kodak and Transpharma Medical.
    [Show full text]
  • Audiocodes AGM Proxy Statement 2021
    Exhibit 99.1 August 10, 2021 Dear Shareholder, You are cordially invited to attend the 2021 Annual General Meeting of Shareholders (the “Meeting”) of AudioCodes Ltd. (the “Company” or “AudioCodes”), to be held on September 14, 2021, at 2:00 p.m., local time, or at any adjournment or postponement thereof, for the purposes set forth herein and in the enclosed Notice of Annual General Meeting of Shareholders. The Meeting will be held at the offices of the Company located at 1 Hayarden Street, Airport City, Lod 7019900, Israel. The telephone number at that address is +972-3-976-4000. The health and well-being of our employees and shareholders are paramount, and we are closely monitoring developments related to the novel coronavirus, or COVID-19. Although we intend to hold the Meeting in person, we are sensitive to the public health and travel concerns our shareholders may have and the protocols that governments may impose. We reserve the right to convert to a virtual only meeting format should meeting in person become unsafe as a result of COVID-19. If we convert to a virtual only online meeting, we will announce the decision to do so in advance and provide instructions for shareholder participation in the virtual meeting in a Form 6-K filed with the Securities and Exchange Commission. As always, we encourage you to vote your shares prior to the Meeting. At the Meeting, shareholders will be asked to consider and vote on the matters listed in the enclosed Notice of Annual General Meeting of Shareholders. AudioCodes’ Board of Directors recommends that you vote FOR all of the proposals listed in the Notice.
    [Show full text]